Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Chem Chem Phys ; 26(5): 4524-4532, 2024 Jan 31.
Article in English | MEDLINE | ID: mdl-38240772

ABSTRACT

Currently, electromagnetic shielding materials need to meet the characteristics of lightweight, high transmittance, and robust conductivity. Silver nanowires (AgNWs) have progressively found applications in recent years owing to their excellent aspect ratio, conductivity, and flexibility. The properties of AgNWs vary with different aspect ratios, and the length and diameter of AgNWs often exert diverse influences on the photoelectric properties of conductive films. In this study, we combined AgNWs with hydroxypropyl methylcellulose (HPMC) and employed a directional stacking arrangement method to apply AgNWs onto the PET substrate, investigating the properties of four distinct aspect ratios of AgNWs (1000, 750, 625, and 531). Ultimately, the prepared four films achieved electromagnetic shielding capabilities ranging from 26.6 dB to 32.8 dB, with a transmittance range of 89.8% to 94.6%, showing excellent electromagnetic shielding properties. Moreover, the prepared films showed an exceedingly low roughness value (RMS = 7.07 nm), remarkable flexibility, and superior oxidation resistance with the facilitation of HPMC. The films also showed exceptional electrothermal conversion prowess, achieving saturation temperature within a mere 8 seconds, thereby displaying a rapid thermal response. Furthermore, when a voltage of 4 V was applied, the temperature of the thin film remained essentially constant for a duration of 2500 seconds, highlighting its admirable thermal stability, which is of great significance for the development of flexible and transparent electromagnetic shielding materials in the future.

2.
Biomed Pharmacother ; 162: 114672, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37060662

ABSTRACT

In recent years, breakthroughs in bioinformatics have been made with the discovery of many functionally significant non-coding RNAs (ncRNAs). The discovery of these ncRNAs has further demonstrated the multi-level characteristics of intracellular gene expression regulation, which plays an important role in assisting diagnosis, guiding clinical drug use and determining prognosis in the treatment process of various diseases. microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) are the three major types of ncRNAs that interact with each other. Studies have shown that lncRNAs and circRNAs can sponge miRNAs, thereby influencing normal physiological processes and regulating mRNA expression and, thus, the physiological state of cells. This paper summarizes the mechanism of action and research progress of the three ncRNA and seven types of modalities. This summary is intended to provide new ideas for diagnosing and treating diseases and researching and developing new drugs.


Subject(s)
MicroRNAs , RNA, Long Noncoding , MicroRNAs/genetics , RNA, Circular/genetics , RNA, Long Noncoding/genetics , Gene Expression Regulation , Computational Biology
3.
Molecules ; 28(5)2023 Feb 24.
Article in English | MEDLINE | ID: mdl-36903369

ABSTRACT

LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.


Subject(s)
Neoplasms , RNA, Long Noncoding , Humans , Cell Line, Tumor , RNA, Long Noncoding/genetics , Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...